Clinical Trials Browser

Phase 2 × Brachytherapy × Gynecologic × Clear all

NCT07276360 2026-03-27

HypoRTCx-UG

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06331468 2025-12-26

Hypofractionated Radiochemotherapy

Phase 2 Recruiting

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT07232654 2025-12-01

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

Phase 2 Completed

43 enrolled 13 charts

GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT02635360 2025-07-03

Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer

Phase 2 Completed

94 enrolled 16 charts

Uterine Cervical Neoplasms

NCT06419673 2024-05-17

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT01041027 2023-10-26

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Phase 2 Terminated

31 enrolled 8 charts

Endometrial Adenocarcinoma

NCT05799469 2023-04-05

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT00492778 2023-03-29

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Phase 2 Unknown

165 enrolled 15 charts

Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

NCT05772377 2023-03-16

Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

Phase 2 Unknown

To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

NCT01399658 2023-03-14

AMIGO

Phase 2 Completed

93 enrolled 5 charts

Uterine Cervical Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05105672 2021-12-28

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT03469531 2018-08-13

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Neoplasms

NCT00369122 2018-03-20

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer

Phase 2 Completed

60 enrolled 8 charts

Uterine Cervical Neoplasms

NCT00590967 2016-08-29

A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy

Phase 2 Terminated

69 enrolled 6 charts

Uterine Cervical Neoplasms

NCT02501278 2016-05-13

A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT02705612 2016-03-10

Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT00462397 2013-08-26

Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT00008112 2013-08-07

Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT00278304 2013-06-20

Radiation Therapy in Treating Patients With Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT01158248 2010-07-09

Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms